Development of a new active ingredient for the treatment of psoriasis with synthesis from plant raw materials: RGH-4417
Keve, T.; Zsadon, B.; Galambos, J.; Barta, K.
Acta Pharmaceutica Hungarica 57(5): 199-207
1987
ISSN/ISBN: 0001-6659 PMID: 3434289 Document Number: 292643
Document emailed within 1 workday
Related Documents
Egermann, H. 1985: Calculation of materials of random mixtures of drug forms with minor proportions of active ingredient (1.) Pharmaceutica Acta Helvetiae 60(12): 322-325Mokhov, E.M.; Sergeev, A.N.; Chumakov, R.I.; Velikov, P.G.; Aleksandrov, I.V. 2009: Stages of the development of new biologically active suture materials and using them in the emergency abdominal surgery Vestnik Khirurgii Imeni I. I. Grekova 168(6): 25-28
Selmeczi, B.; Kedvessy, G.; Nagy, G.; Pintyéné Hódi, K.; Tencova, A.; Kiszeleva, G. 1981: Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient Acta Pharmaceutica Hungarica 51(5): 222-227
Przybilla, B.; Schwab, U.; Hölzle, E.; Ring, J. 1983: Contact sensitization to an antiperspirant with the active ingredient propantheline bromide Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 34(9): 459-462
Zeng, L.L.; Wang, G.Y.; Wang, D.X.; Chen, C.H.; Xu, S.Y. 1982: Studies on the active ingredient of Curcuma aromatica Salisb and its effects Yao Xue Xue Bao 17(12): 946-950
Rao, M.S.; Nair, P.; Pratap, C. 1973: Induction of mutations by thioridazine hydrochloride, an active ingredient of Mellaril Indian Journal of Experimental Biology 11(5): 403-404
Russell, A.S.; Aghazadeh-Habashi, A.; Jamali, F. 2002: Active ingredient consistency of commercially available glucosamine sulfate products Journal of Rheumatology 29(11): 2407-2409
Saito, T.; Kobayashi, Y.; Shiga, T.; Arakawa, Y.; Takai, M.; Shimanuki, M.; Tani, A.; Goto, E.; Kitaya, Y.; Takahashi, H. 1999: Development of plant growth chambers for the experiments under microgravity conditions--development of measurement system of plant water uptake Uchu Seibutsu Kagaku 13(3): 226-227
Liu, C.-L.; Yin, Y.; Zhang, S.-H.; Li, Q.; Chen, M.; Guo, X. 2014: Study on correlation between trace elements and active ingredient in glycyrrhizae radix et rhizome Zhongguo Zhong Yao Za Zhi 39(17): 3335-3338
Hagemann, P. 1978: In vitro active ingredient liberation of five commercial prednisolone preparations in tablet form Pharmaceutica Acta Helvetiae 53(5): 133-135
Zhou, W-bin.; Lin, L.; Li, Z-yong.; Bi, T.; Ye, T-yuan.; Ma, C-qiang.; Bao Hong-juan; Wang, H-ping.; Zhang, B-xia.; Song, K-kui.; Li, Y-wen.; Wang, Y. 2015: Study on active ingredient and mechanism in preventing vascular dementia of Tianzhusan coming from Tujia medicine Zhongguo Zhong Yao Za Zhi 40(13): 2668-2673
Miseta, M.; Kedvessy, G.; Selmeczi, B. 1983: Influence of the pressing force on the physical features of sulfathiazole tablets and the dissolution rate of the active ingredient Die Pharmazie 38(5): 326-327
Georgetson, M.J.; Yarze, J.C.; Lalos, A.T.; Webster, G.F.; Martin, P. 1993: Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis American Journal of Gastroenterology 88(10): 1756-1758
Giannattasio, F.; Salvio, A.; Varriale, M.; Picciotto, F.P.; Di Costanzo, G.G.; Visconti, M. 2002: Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 17(3): 180-184
Gayot, A.; Blouet, E.; Leterme, P.; Traisnel, M. 1988: Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient Bollettino Chimico Farmaceutico 127(9-10): 218-220
López de Landache, I.E.; Braceras Izaguirre, L.; Echeto García, A.; Gardeazabal Romillo, M.J.é; Acevedo Heranz, P. 2013: Efficiency in the prescription of drugs. Impact of a health policy: automatic change to prescription by active ingredient Revista de Enfermeria 36(11): 49-52
Otani, Y.; Kawagoe, T. 1968: Contraceptive effects of a jelly with a surface active agent as the basic and ingredient clinical experiences with a new contraceptive drug, Penicap Sanfujinka no Jissai. Practice of Gynecology and Obstetrics 17(7): 657-659
Ruddy, D.A.; Sherma, J. 2002: Determination of the active ingredient loperamide hydrochloride in pharmaceutical caplets by high performance thin layer chromatography with ultraviolet absorption densitometry of fluorescence quenched zones Acta Poloniae Pharmaceutica 59(1): 15-18
Pietrzak, A.; Chodorowska, G.; Jazienicka, I.; Junak-Bojarska, A.; Roliński, J. 2003: New development in the treatment of psoriasis--infliximab Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 322-327
Farrell-Miller, P.; Gentry, P. 1989: Professional Development: How Effective Are Your Patient Education Materials? Guidelines for Developing and Evaluating Written Educational Materials The Diabetes Educator 15(5): 418-422